Caricamento...
2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases
BACKGROUND: Data on patients with inflammatory bowel diseases (IBD) who have had 2019 novel coronavirus (SARS‐CoV‐2) disease (COVID‐19) are needed. AIMS: To report the clinical characteristics, including gastrointestinal symptoms, of COVID‐19 in IBD patients, and to assess the risk of COVID‐19 in IB...
Salvato in:
| Pubblicato in: | Aliment Pharmacol Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267496/ https://ncbi.nlm.nih.gov/pubmed/32359205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15804 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|